Navigation Links
sPLA2 in Medical News

Experimental Drug May Prevent Plaque Buildup

...atherosclerosis are produced when enzymes known as spla2 break down particular molecules in the blood and a...e of The Lancet . "Our study demonstrates that spla2 inhibition produces favorable changes in plasma li...rther study is needed to determine "the effects of spla2 inhibition on reducing atherosclerosis progression...
sPLA2 in Medical Technology

Anthera's Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome

...-HDL cholesterol - Varespladib's immediate and selective inhibition of spla2 effectively suppressed inflammation following the index event and was furth...nt markers of cardiovascular risk including, a near complete suppression of spla2 activity and mass, clinically meaningful and statistically significant redu...

Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease

...d Chief Medical Officer of Anthera Pharmaceuticals, Inc. "We believe a drug that is deemed to be safe and able to suppress inflammation by inhibiting spla2 provides an opportunity for early intervention for patients where current treatment options are limited." "Today's announcement marks an exciting...

Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial

... Phase IIb clinical trial of A-002, for the treatment of cardiovascular disease. In this second study, administration of once-daily A-002 lowered both spla2 and LDL-C levels confirming the positive effects of A-002 treatment seen in the twice-daily PLASMA study (Phospholipase Levels And Serological Markers...

Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease

...rvention for a serious inflammatory lung disease with a potent inhibitor of spla2 such as A-001. Worldwide, nearly 200,000 suffer from some form of sickle ce...even the common complications of sickle cell disease. As such, discovery of spla2 as a potential therapeutic target for patients at risk for acute chest synd...

Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease

...g of A-002, suggests that a single daily dose may be sufficient to suppress spla2 for up to 24 hours. We look forward to further exploring this opportunity t...irst half of 2008. Further information about Anthera's clinical trials and spla2 can be found at http://www.PLASMAtrial.com or http://www.anthera.com . ...
sPLA2 in Biological Technology

Anthera Presents Data on Varespladib at ATVB Meeting

...ow-Density Lipoproteins in CHD Patients with Diabetes. -- The Synergistic Inhibition of Atherogenesis in ApoE-/- Mice Between Pravastatin and the spla2 Inhibitor Varespladib (A-002). "We are pleased to see the synergistic effect of Varespladib with statins on plaque reduction, composition and stabil...
Other Tags
(Date:7/28/2014)... NY (PRWEB) July 28, 2014 Glutamine ... body and it’s considered to be conditionally essential during ... and is an advanced recovery & Immune System Support. ... the glutamine your body produces, supplementing with additional glutamine ... of waste products in the body, digestion and immune ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, ... who are at risk of contracting meningitis because of ... according to updated recommendations from the largest pediatrician group ... for the potentially deadly infection should continue for adolescents ... In its first statement on meningococcal vaccines since ...
(Date:7/28/2014)... runners are far more likely to die of heat ... new study. The researchers pointed out that ... actually 10 times more likely to develop severe and ... of a young and apparently healthy person due to ... gets a lot more media attention. "This research ...
(Date:7/28/2014)... 28, 2014 SIMpalm helped its ... App is available on iTunes for download . Experience ... Audio Chef allows you to listen and cook along with ... way: simply get out the ingredients and equipment, press play, ... or prepare ingredients ahead of time, just relax and cook ...
(Date:7/28/2014)... NY (PRWEB) July 28, 2014 The ... organization that has donated more than 200,000 books to ... 2001, announces the launch of Brooke’s Cooks, a new ... while encouraging healthy living among at-risk children and their ... will include a series of nutrition information workshops, cooking ...
Breaking Medicine News(10 mins):Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 4
(Date:7/28/2014)... (July 28, 2014) Rice University researchers are using ... varying flexibility that can be used as microscale models ... that "bead-spring" polymers, introduced as theory in the 1950s, ... required and should be of interest to materials scientists ... work led by Rice chemical and biomolecular engineer Sibani ...
(Date:7/28/2014)... A powerful new tool that can help advance ... green and renewable bioenergy, has been developed by ... Joint BioEnergy Institute (JBEI), a multi-institutional partnership led ... JBEI researchers have developed an assay that enables ... nucleotide sugar transporters, critical components in the biosynthesis ...
(Date:7/28/2014)... the body,s natural virus killers to prevent and treat ... the strong inflammatory response these molecules can arouse as ... conducted by scientists at the Weizmann Institute and the ... the activity of these molecules interferons around ... the course of the disease. Their research appeared in ...
Breaking Biology News(10 mins):Seeing is bead-lieving 2How sweet it is 2How sweet it is 3Interfering with interferon 2
Other Contents